March 5, 2020
Koch Institute for Integrative Cancer Research at MIT,
From scientific breakthrough to commercial opportunity: Overcoming the business challenges of oncology development
An invitation-only, off-the-record forum that brings together the past, present and future leaders to network and share expertise in cancer therapeutics.
What to Expect
Sessions and Fireside Chats
With a room full of oncology experts and industry thought-leaders, the program has been designed to facilitate participation. Engage with speakers and challenge your peers with open discussion focused on game-changing cancer therapeutics.
Mingle with senior-level peers during networking breaks and receptions to continue conversation from panel discussions and build important relationships.
2020 Keynote Speakers
David H. Koch Professor of Engineering at the Koch Institute for Integrative Cancer Research and Head of the Department of Chemical Engineering
2020 Steering Committee
Meet the Cancer Advance Steering Committee, a distinguished group of industry thought leaders whose insights have helped shape our program into one that brings the most relevant players in the biopharma space to the table.
Interested in sponsorship opportunities?
Sponsor an upcoming LeadingBiotech event to enhance your visibility and demonstrate your expertise to a highly qualified audience of c-level decision makers. All programs are custom-built to align with your unique objectives and may include speaking engagement, passes, branding, and more.
New Name. New Direction.
Boston Biotech Conferences is now LeadingBiotech
Boston Biotech Conferences is moving in a new direction, including a new name! We’re working hard to create a more valuable experience for our intimate community of senior-level industry leaders through: ✓ Re-energized CEO events ✓ New leadership roles ✓ New format & pricing